Linking Physical Activity to Breast Cancer Risk via Inflammation, Part 1: The Effect of Physical Activity on Inflammation.


Journal

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
ISSN: 1538-7755
Titre abrégé: Cancer Epidemiol Biomarkers Prev
Pays: United States
ID NLM: 9200608

Informations de publication

Date de publication:
01 05 2023
Historique:
received: 25 08 2022
revised: 10 12 2022
accepted: 27 02 2023
medline: 2 5 2023
pubmed: 4 3 2023
entrez: 3 3 2023
Statut: ppublish

Résumé

The protective effect of physical activity on breast cancer incidence may partially be mediated by inflammation. Systematic searches of Medline, EMBASE, and SPORTDiscus were performed to identify intervention studies, Mendelian randomization studies, and prospective cohort studies that examined the effects of physical activity on circulating inflammatory biomarkers in adult women. Meta-analyses were performed to generate effect estimates. Risk of bias was assessed, and the Grading of Recommendations Assessment, Development, and Evaluation system was used to determine the overall quality of the evidence. Thirty-five intervention studies and one observational study met the criteria for inclusion. Meta-analyses of randomized controlled trials (RCT) indicated that, compared with control groups, exercise interventions reduced levels of C-reactive protein (CRP) [standardized mean difference (SMD) = -0.27, 95% confidence interval (CI) = -0.62 to 0.08), tumor necrosis factor alpha (TNFα, SMD = -0.63, 95% CI = -1.04 to -0.22), interleukin-6 (IL6, SMD = -0.55, 95% CI = -0.97 to -0.13) and leptin (SMD = -0.50, 95% CI = -1.10 to 0.09). Owing to heterogeneity in effect estimates and imprecision, evidence strength was graded as low (CRP, leptin) or moderate (TNFα and IL6). High-quality evidence indicated that exercise did not change adiponectin levels (SMD = 0.01, 95% CI = -0.14 to 0.17). These findings provide support for the biological plausibility of the first part of the physical activity-inflammation-breast cancer pathway.

Identifiants

pubmed: 36867865
pii: 718590
doi: 10.1158/1055-9965.EPI-22-0928
pmc: PMC10150243
mid: EMS171119
doi:

Substances chimiques

Leptin 0
Tumor Necrosis Factor-alpha 0
Interleukin-6 0
C-Reactive Protein 9007-41-4

Types de publication

Observational Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

588-596

Subventions

Organisme : Cancer Research UK
ID : A29019
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : R01 CA215797
Pays : United States
Organisme : Department of Health
ID : NIHR202411
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

©2023 The Authors; Published by the American Association for Cancer Research.

Références

Exp Gerontol. 2021 Jul 15;150:111398
pubmed: 33965553
J Physiol. 2020 Feb;598(3):503-515
pubmed: 31873952
Med Sci Sports Exerc. 2010 Feb;42(2):314-25
pubmed: 19927028
Arch Physiol Biochem. 2015 May;121(2):50-5
pubmed: 25720859
J Appl Physiol (1985). 2005 Sep;99(3):1193-204
pubmed: 16103522
J Strength Cond Res. 2017 Nov;31(11):2955-2964
pubmed: 29065076
Clinics (Sao Paulo). 2013;68(8):1121-7
pubmed: 24037008
Med Sci Sports Exerc. 2019 Jun;51(6):1262-1269
pubmed: 31095083
J Phys Act Health. 2017 Jun;14(6):479-485
pubmed: 28253046
Cancer Epidemiol Biomarkers Prev. 2022 Jan;31(1):16-27
pubmed: 34670800
Cancer Epidemiol Biomarkers Prev. 2022 Dec 5;31(12):2106-2115
pubmed: 36464996
Eur J Sport Sci. 2022 Feb;22(2):218-226
pubmed: 33317411
Menopause. 2016 Dec;23(12):1330-1338
pubmed: 27529462
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
J Sports Sci. 2008 Feb 1;26(3):303-9
pubmed: 17943596
Brain Behav Immun. 2011 Jul;25(5):811-6
pubmed: 21354469
Clin Chim Acta. 2010 Jun 3;411(11-12):785-93
pubmed: 20188719
Nat Rev Cancer. 2008 Mar;8(3):205-11
pubmed: 18235448
Int J Sports Med. 2008 Feb;29(2):102-9
pubmed: 17990210
Nutr Metab (Lond). 2011 Oct 15;8:71
pubmed: 21999620
JAMA. 2021 Oct 26;326(16):1614-1621
pubmed: 34698778
Int J Environ Res Public Health. 2020 Mar 02;17(5):
pubmed: 32131554
Menopause. 2013 Feb;20(2):185-93
pubmed: 23096247
Cancer Res. 2012 May 1;72(9):2314-26
pubmed: 22549948
Med Sci Sports Exerc. 2012 Nov;44(11):2099-110
pubmed: 22874536
Cancer Epidemiol Biomarkers Prev. 2022 Jan;31(1):28-37
pubmed: 34670801
Cancer Causes Control. 2019 Nov;30(11):1183-1200
pubmed: 31471762
Appl Physiol Nutr Metab. 2012 Dec;37(6):1019-27
pubmed: 22891799
Cancer Epidemiol Biomarkers Prev. 2016 May;25(5):799-806
pubmed: 26908432
Med Sci Sports Exerc. 2011 Jun;43(6):1002-9
pubmed: 21085036
Environ Int. 2019 Jan;122:168-184
pubmed: 30473382
J Intern Med. 2013 Aug;274(2):163-75
pubmed: 23432360
Cancer Prev Res (Phila). 2016 Feb;9(2):196-203
pubmed: 26603740
Arch Phys Med Rehabil. 2013 Apr;94(4):660-6
pubmed: 23168399
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Int J Obes (Lond). 2007 Jun;31(6):996-1003
pubmed: 17299382
Cancer Epidemiol Biomarkers Prev. 2017 Nov;26(11):1667-1675
pubmed: 28978562
J Appl Physiol (1985). 2015 Oct 15;119(8):918-25
pubmed: 26338453
Metabolism. 2013 Jan;62(1):127-36
pubmed: 22898251
J Phys Act Health. 2018 Jan 1;15(1):64-71
pubmed: 28771081
J Diabetes. 2018 Apr;10(4):328-337
pubmed: 29031002
Br J Sports Med. 2022 Oct;56(20):1157-1170
pubmed: 36328784
Cancer Prev Res (Phila). 2012 Jan;5(1):98-108
pubmed: 21982875
Nature. 2002 Dec 19-26;420(6917):860-7
pubmed: 12490959
Front Physiol. 2020 Sep 09;11:567881
pubmed: 33013484
Am J Physiol Regul Integr Comp Physiol. 2016 Nov 1;311(5):R841-R850
pubmed: 27534876
Cancer Epidemiol Biomarkers Prev. 2022 Jan;31(1):11-15
pubmed: 34670802
Menopause. 2018 Sep;25(9):1004-1010
pubmed: 29787478
Med Sci Sports Exerc. 2019 Jun;51(6):1252-1261
pubmed: 31095082
Physiol Behav. 2017 Oct 1;179:290-297
pubmed: 28687176
Neuroimmunomodulation. 2009;16(4):237-44
pubmed: 19365147
J Aging Res. 2011 Jan 04;2011:512593
pubmed: 21253483
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
J Appl Physiol (1985). 2005 Apr;98(4):1154-62
pubmed: 15772055
Immunity. 2019 Jul 16;51(1):27-41
pubmed: 31315034
J Sports Sci. 2021 Mar;39(5):496-502
pubmed: 33012244
Sports Med. 2013 Apr;43(4):243-56
pubmed: 23494259
Med Sci Sports Exerc. 2009 Aug;41(8):1533-9
pubmed: 19568208
Cancer Epidemiol Biomarkers Prev. 2023 May 1;32(5):597-605
pubmed: 36867866
Appl Physiol Nutr Metab. 2016 Dec;41(12):1262-1270
pubmed: 27841026
Eur J Appl Physiol. 2013 Dec;113(12):2925-32
pubmed: 24068487
Front Endocrinol (Lausanne). 2020 Dec 11;11:531926
pubmed: 33362710
Post Reprod Health. 2015 Mar;21(1):9-15
pubmed: 25710943
Cancer Epidemiol Biomarkers Prev. 2022 Dec 5;31(12):2116-2125
pubmed: 36464995
Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1725-1734
pubmed: 31383718

Auteurs

Christopher T V Swain (CTV)

Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.

Ann E Drummond (AE)

Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.

Roger L Milne (RL)

Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia.

Dallas R English (DR)

Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.

Kristy A Brown (KA)

Department of Medicine, Weill Cornell Medicine, New York, New York.

Makayla W C Lou (MWC)

Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.

Leonessa Boing (L)

Laboratory of Research in Leisure and Physical Activity, Santa Catarina State University, Florianopolis, Brazil.

Amy Bageley (A)

Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.

Tina L Skinner (TL)

The University of Queensland, School of Human Movement and Nutrition Sciences, St Lucia, Australia.

Eline H van Roekel (EH)

Department of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands.

Melissa M Moore (MM)

Medical Oncology, St Vincent's Hospital, Melbourne, Australia.
Department of Medicine, The University of Melbourne, Melbourne, Australia.

Tom R Gaunt (TR)

Bristol Medical School, University of Bristol, Bristol, UK.

Richard M Martin (RM)

Bristol Medical School, University of Bristol, Bristol, UK.
NIHR Biomedical Research Centre at University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK.

Sarah J Lewis (SJ)

Bristol Medical School, University of Bristol, Bristol, UK.

Brigid M Lynch (BM)

Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
Physical Activity Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH